Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft

Inclusion Criteria: * Unilateral or bilateral aorto-iliac or iliac aneurysm * Suitable for endovascular repair * Patient must be compliant with life- long follow-up investigations * \>18 years old * lliac/femoral access vessel morphology compatible with the implantation procedure and the 18Fr (6mm OD) delivery system * Non-aneurysmal common iliac artery landing area in case of iliac artery aneurysm ≥ 20mm * Diameter of the common iliac artery in the proximal landing area: 12mm to 17mm * Non-aneurysmal external iliac artery segment distal to the aneurysm ≥15mm * Diameter of the external iliac artery in the distal landing area: 8mm to 13mm * Non-aneurysmal internal iliac artery segment distal to the aneurysm ≥15mm * Angle between external iliac artery and internal iliac artery ≤50° * Thrombus free iliac lumen in the area of iliac bifurcation to open hypogastric side branch and to implant covered stent ≥18mm * Sufficiently open internal iliac arterv ostium * Patients must comply with the instructions for use. * Patients with common iliac aneurysm with a diameter ≥30mm when isolated or common iliac aneurysm with a diameter \>25mm when associated with an abdominal aortic aneurysm * Unilateral or bilateral common iliac aneurysm * Patient's anatomy must be fit for stent graft placement on preoperative angio CT scan. * Patient is affiliated to the social security or equivalent system. * The patient must be available for the appropriate follow-up times for the duration of the study. * Patient has been informed of the nature of the study, agrees to its provisions and has signed the informed consent from. Exclusion Criteria: * Patients who do not meet the instructions for use * Patients with one of the contraindications as indicated in the instructions for use * Patients with a stenotic internal iliac ostium of \< 4mm in Diameter * Patients with severe internal iliac atherosclerosis * Patients that do not have a suitable landing area in the main stem of the IIA (maximum diameter in landing area \<12mm) * Patients with pseudoaneurysms * Patients with symptomatic and ruptured iliac aneurysms * Patients pretreated with a AAA stent graft or a bifurcated vascular graft * Patient with thrombocytopenia * Patient with an estimated glomerular filtration rate \< 30 ml/min/1,73m2 immediately before the Intervention * Female of child bearing potential * In the lnvestigator's opinion patient has (a) eo-morbid condition(s) that could limit the patient's ability to participate in the study, compliance with follow-up requirements, or impact the scientific integrity of the study * Patient is currently participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the current study endpoints * Patient with malignancy needing chemotherapy or radiation * Patients with life expectancy of less than 36 months * Patient minor or under guardianship